Champions Oncology, Inc. - stock earnings
CSBR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q1 | -2.4 million USD | 12.8 million USD |
2022Q4 | -16000 USD | 14.3 million USD |
2022Q3 | -319000 USD | 13.7 million USD |
2022Q2 | -344000 USD | 12.9 million USD |
2022Q1 | 787000 USD | 13.2 million USD |
2021Q4 | 277000 USD | 11.8 million USD |
2021Q3 | -172000 USD | 11.3 million USD |
2021Q2 | -454000 USD | 10.6 million USD |
2021Q1 | 740000 USD | 10.8 million USD |
2020Q4 | 1000 USD | 10.1 million USD |
2020Q3 | 75000 USD | 9.5 million USD |
2020Q2 | -2.0 million USD | 8.7 million USD |
CSBR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -5.3 million USD | 53.9 million USD |
2022 | 548000 USD | 49.1 million USD |
2021 | 362000 USD | 41.0 million USD |
2020 | -2.0 million USD | 32.1 million USD |
2019 | 128000 USD | 27.1 million USD |
2018 | -1.5 million USD | 20.2 million USD |
2017 | -6.9 million USD | 15.4 million USD |
2016 | -10.4 million USD | 11.2 million USD |
2015 | -13.1 million USD | 8.9 million USD |
2014 | -7.4 million USD | 11.6 million USD |
2013 | -6.4 million USD | 8.3 million USD |
2012 | -8.7 million USD | 7.1 million USD |
2011 | -3.8 million USD | 6.9 million USD |
2010 | -2.9 million USD | 4.9 million USD |
2009 | -2.2 million USD | 3.7 million USD |
2008 | 35698 USD | 1.4 million USD |
2007 | -170058 USD | ? USD |
2006 | -303718 USD | ? USD |
2005 | -246544 USD | 1.8 million USD |
2004 | -107687 USD | 2.0 million USD |
2003 | -145994 USD | 2.0 million USD |
2002 | -147312 USD | 2.1 million USD |
2001 | -676883 USD | 2.2 million USD |
2000 | 51512 USD | 2.2 million USD |
1999 | 20000 USD | 2.2 million USD |
1998 | 360000 USD | 2.3 million USD |
1997 | 290000 USD | 2.2 million USD |
1996 | 50000 USD | 2.1 million USD |
CSBR
Price: $4.80
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -8.55
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 67.7 million